INSTANTRAPID Trademark

Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Coronavirus, Influenza A and B, Sexually Transmitted Diseases, HIV, Hepatitis, TB and other detectible antibodies.; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents and contrast media for medical use; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test media in the form of rapid result test strips for measuring qualitative and quantitative immunological and enzymatic assays; Medical diagnostic test strips for use in the field of infectious diseases and chronic care management; Medical diagnostic test strips for rapid result test strips for measuring qualitative and quantitative immunological and enzymatic assays; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol, amphetamines, barbiturates, benzodiazepines, methadone, cocaine, opiates, including codeine, oxycodone, and heroin, phencyclidine (PCP) and tetrahydrocannabinol (THC); Reagents and media for medical and veterinary diagnostic purposes